All Stories

  1. Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance

    Article • Risk Management and Healthcare Policy, August 2018, Dove Medical Press

    Dr Alyssa Peckham, Maria Ananickal